BRCA1 and breast carcinoma: In regards to their combinatory effect, MD and BRCA1/2 gene mutation carrier status in one study did not report a link to enhanced breast cancer risk [19], whereas in the largest cohort study of women to date on the subject, it was found that MD was an independent risk factor for breast cancer in BRCA1/2 gene mutation carriers [20].